Gene · 239
Papers2,360
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,360
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRPM2 Mediates Hepatic Ischemia-Reperfusion Injury via Ca2+-Induced Mitochondrial Lipid Peroxidation through Increasing ALOX12 Expression. | Research (Wash D C) | 2023 | 37275121 | PubTator, text mining | PubMed |
| Ferroptosis as an emerging therapeutic target in liver diseases. | Front Pharmacol | 2023 | 37256232 | PubTator, text mining | PubMed |
| Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy. | Oxid Med Cell Longev | 2023 | 37251440 | PubTator, text mining | PubMed |
| GC/MS-Based Analysis of Fatty Acids and Amino Acids in H460 Cells Treated with Short-Chain and Polyunsaturated Fatty Acids: A Highly Sensitive Approach. | Nutrients | 2023 | 37242225 | PubTator, text mining | PubMed |
| Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease. | J Pers Med | 2023 | 37241000 | PubTator, text mining | PubMed |
| Polyunsaturated Fatty Acids: Conversion to Lipid Mediators, Roles in Inflammatory Diseases and Dietary Sources. | Int J Mol Sci | 2023 | 37240183 | PubTator, text mining | PubMed |
| Biomarkers of Neurodegeneration in Post-Traumatic Stress Disorder: An Integrative Review. | Biomedicines | 2023 | 37239136 | PubTator, text mining | PubMed |
| Potential Benefits of Omega-3 Polyunsaturated Fatty Acids (N3PUFAs) on Cardiovascular Health Associated with COVID-19: An Update for 2023. | Metabolites | 2023 | 37233671 | PubTator, text mining | PubMed |
| The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases. | MedComm (2020) | 2023 | 37229485 | PubTator, text mining | PubMed |
| Targeting ferroptosis, a novel programmed cell death, for the potential of alcohol-related liver disease therapy. | Front Pharmacol | 2023 | 37214434 | PubTator, text mining | PubMed |
| Design, synthesis and evaluation of 2-aryl quinoline derivatives against 12R-lipoxygenase (12R-LOX): Discovery of first inhibitor of 12R-LOX. | Bioorg Chem | 2023 | 37210826 | PubTator, text mining | PubMed |
| Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment. | Cell Commun Signal | 2023 | 37208730 | PubTator, text mining | PubMed |
| WIPI2 enhances the vulnerability of colorectal cancer cells to erastin via bioinformatics analysis and experimental verification. | Front Oncol | 2023 | 37207153 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and Leukemia. | Cells | 2023 | 37190037 | PubTator, text mining | PubMed |
| COVID-19, Blood Lipid Changes, and Thrombosis. | Biomedicines | 2023 | 37189799 | PubTator, text mining | PubMed |
| Butyrate dictates ferroptosis sensitivity through FFAR2-mTOR signaling. | Cell Death Dis | 2023 | 37185889 | PubTator, text mining | PubMed |
| Redox Systems Biology in Chronic Kidney Disease. | Oxid Med Cell Longev | 2023 | 37180759 | PubTator, text mining | PubMed |
| Ferroptosis in hematological malignant tumors. | Front Oncol | 2023 | 37139157 | PubTator, text mining | PubMed |
| Effects of inhibition of 5-lipoxygenase and 12-lipoxygenase pathways on skeletal muscle fiber regeneration. | Chem Biol Interact | 2023 | 37116854 | PubTator, text mining | PubMed |
| Multi-walled carbon nanotubes induce arachidonate 5-lipoxygenase expression and enhance the polarization and function of M1 macrophages in vitro. | Nanotoxicology | 2023 | 37115655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/239/papers?page=11